Rutan

N/A

Report date: 2023/05/17 20:00:39
NME

Base Information

Drug NameRutan
Drug Alias NameRutan 0.13,6-bis-O-galloyl-1,2,4-tri-O-galloyl-β-D-glucose
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUzbekistan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesResearch Institute of Virology, Ministry of Health of the Republic of Uzbekistan
China Registration ClassN/A

Develop Information

Active CompaniesResearch Institute of Virology, Ministry of Health of the Republic of Uzbekistan
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A